Liver Diseases  >>  furaprevir (TG-2349)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
furaprevir (TG-2349) / TaiGen
NCT02340962: Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection

Completed
2
25
RoW
TG-2349, Ribavirin, Interferon Alfa-2a
TaiGen Biotechnology Co., Ltd.
Hepatitis C, Chronic
08/16
10/16

Download Options